Rivaling Eli Lilly’s (NYSE:LLY) direct-to-consumer platform LillyDirect, which made its market debut last year, Novo Nordisk ...
Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says Bitcoin Created “Froth” In The Market. In ...
Following the results of a study by USC Annenberg Inclusion Initiative demonstrating the lack of adequate representation of ...
Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is ...
We recently compiled a list of the 30 Best Stocks To Invest In According to Billionaires. In this article, we are going to ...
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
We recently compiled a list of the Top 10 Stocks to Buy According to Lone Pine Capital. In this article, we are going to take ...
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of ...
Lilly’s 1st DTC Ebglyss campaign highlights eczema’s effects on a range of skin tones and age groups
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Eli Lilly plans to invest at least $27 billion to build four new manufacturing sites in the U.S., a week after President Trump reportedly said he planned to impose tariffs of 25% or more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results